Samsung Biologics Bets 2.7 Trillion Won on Peptides in South Korea’s Largest Biotech M&A Deal
Samsung Biologics is making a major push into peptide-based medicines—widely used in weight-loss and diabetes therapies—through the planned...
Search results for "K-Bio"
Celltrion Secures South Korean Phase 1 Approval for Tremfya Biosimilar CT-P68
Celltrion announced on July 15 that it has received approval from South Korea’s Ministry of Food and Drug Safety for an investigational new drug...
Fast-Tracking Biosimilars: South Korea to Waive Phase 3 Clinical Trials Under New Guidelines
South Korean regulators have revised requirements to significantly reduce the time and financial burden of biosimilar...
Landmark Biotech Deal: Celltrion Acquires Autoimmune Disease Antibody Tech from Catholic University of Korea
A research team led by Kim Wan-wook at the Catholic University of Korea College of Medicine has successfully...
GC Biopharma to Conduct Phase 3 Clinical Trial for Two-Dose Chickenpox Vaccine in South Korea
GC Biopharma’s chickenpox vaccine, Barycela Inj., is set to enter a Phase 3 clinical trial in South Korea to confirm...
Beyond the Paleolithic Myth: Why Human Biology Clashes with the Carnivore Diet
What proportion of human history does the Paleolithic era actually represent? The Paleolithic period spans from roughly...
MSD Bets $510M on High-Quality Data to Fuel Post-Keytruda AI Drug Discovery
MSD, which has long dominated the global cancer market with its blockbuster immuno-oncology therapy Keytruda, is...
Kyungpook National University Hospital Establishes Precision Medicine Infrastructure for High-Throughput Proteomic Analysis
Kyungpook National University Hospital is building an advanced research infrastructure capable of profiling thousands...
Reengineering Your Morning Routine: The Biological Case for Water, Breakfast, and Coffee
What is the very first thing you do when you open your eyes in the morning? While the habit has fortunately declined,...
South Korean Researchers Discover Compound That Destroys Chemo-Resistant Liver Cancer Cells
Cancer cells that no longer respond to chemotherapy present one of the most formidable challenges in oncology.